| Insideraktier | 12.138.101 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Conatus Pharmaceuticals Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CNAT / Conatus Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CNAT / Conatus Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | I | 1.235 | ||||||||
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | D | 979 | ||||||||
| 2022-02-25 | 2022-02-24 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,24 | 151.642 | 151.642 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,24 | 169.800 | 169.800 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,24 | 134.900 | 134.900 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Latterich Martin | HSTO | Restricted Stock Unit | D | 102.880 | 102.880 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Restricted Stock Unit | D | 228.395 | 228.395 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,73 | 377.830 | 377.830 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Knudson Susan A. | HSTO | Restricted Stock Unit | D | 137.174 | 137.174 | ||||||
| 2021-09-03 | 2021-09-02 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 0,82 | 20.000 | 20.000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 0,82 | 20.000 | 20.000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 0,82 | 25.000 | 25.000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,82 | 20.000 | 20.000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 0,82 | 20.000 | 20.000 | |||||
| 2021-03-30 | 2021-03-30 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,1400 | 20.000 | 23 | 30.000 | ||||
| 2021-03-26 | 2021-03-25 | 4 | Fuhrmann Rochelle | HSTO | Stock Option (right to buy) | D | 1,27 | 30.000 | 30.000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Windham-Bannister Susan Richards | HSTO | Stock Option (right to buy) | D | 1,23 | 30.000 | 30.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 0,97 | 346.000 | 346.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,97 | 95.000 | 95.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,97 | 90.000 | 90.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,97 | 112.000 | 112.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 0,97 | 100.000 | 100.000 | |||||
| 2020-12-07 | 2020-12-03 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,2394 | 10.000 | 12 | 10.000 | ||||
| 2020-10-19 | 2020-10-16 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 2,27 | 65.000 | 65.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Zhang Yizhuo | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 4,61 | 124.119 | 124.119 | |||||
| 2020-05-28 | 2018-05-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 35.855 | 35.855 | |||||
| 2020-05-28 | 2017-10-25 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 4.302 | 4.302 | |||||
| 2020-05-28 | 2017-05-22 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,70 | 17.210 | 17.210 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Zhang Yizhuo | HSTO | Common Stock | I | 600.983 | 600.983 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Chang Stephen | HSTO | Common Stock | D | 14.485 | 14.485 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 3,84 | 35.855 | 35.855 | |||||
| 2020-05-28 | 2016-01-29 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,47 | 14.342 | 14.342 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Jackson Jonathan | HSTO | Common Stock | I | 2.356.597 | 2.356.597 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Latterich Martin | HSTO | Common Stock | D | 11.951 | 11.951 | ||||||
| 2020-05-28 | 2018-03-12 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,84 | 14.342 | 14.342 | |||||
| 2020-05-28 | 2016-10-07 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,70 | 28.684 | 28.684 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Satz Brian | HSTO | Common Stock | D | 1.434 | 1.434 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 3,84 | 35.855 | 35.855 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Naughton Gail K | HSTO | Common Stock | I | 426.526 | 426.526 | ||||||
| 2020-05-28 | 2012-05-12 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,53 | 380.063 | 380.063 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 194.071 | 194.071 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 291.107 | 291.107 | |||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Restricted Stock Units | D | -65.000 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 0,5600 | -31.428 | -18 | 39.572 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 65.000 | 71.000 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Restricted Stock Units | D | -31.343 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 0,5600 | -12.960 | -7 | 19.595 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 31.343 | 32.555 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Restricted Stock Units | D | -38.500 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 0,5600 | -18.615 | -10 | 19.885 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 38.500 | 38.500 | ||||||
| 2019-11-19 | 2019-11-18 | 4 | Scott Kathleen D. | CNAT | Stock Option (Right to Buy) | D | 0,33 | 30.000 | 30.000 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Restricted Stock Units | D | 385.000 | 385.000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | -175.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | -70.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | -525.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Restricted Stock Units | D | 313.436 | 313.436 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | -175.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | -70.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | -100.625 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | -21.875 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | -109.375 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | -100.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | -50.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Restricted Stock Units | D | 86.375 | 86.375 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | -50.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | -16.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 4,21 | -23.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,09 | -20.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | -3.750 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | -15.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,61 | -15.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 6,40 | -15.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,45 | -15.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Restricted Stock Units | D | 650.000 | 650.000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | -350.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | -120.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | -172.500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | -37.500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | -20.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | -50.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | -150.000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | -400.000 | 0 | |||||
| 2019-07-01 | 2019-06-27 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,29 | 45.000 | 45.000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100.000 | 100.000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,1500 | 1.861 | 6 | 32.431 | ||||
| 2019-02-11 | 2018-05-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,3100 | 1.290 | 4 | 30.570 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175.000 | 175.000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100.000 | 100.000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,1500 | 1.724 | 5 | 10.875 | ||||
| 2019-02-11 | 2018-05-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,3100 | 4.690 | 16 | 9.151 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175.000 | 175.000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | 50.000 | 50.000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | 350.000 | 350.000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175.000 | 175.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20.000 | 20.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20.000 | 20.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20.000 | 20.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20.000 | 20.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20.000 | 20.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,99 | 45.000 | 45.000 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | -60.000 | 147.070 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 60.000 | 59 | 60.000 | ||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,24 | -12.121 | 0 | |||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Common Stock | D | 1,2400 | 12.121 | 15 | 12.121 | ||||
| 2018-02-05 | 2017-05-30 | 5 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | -2.165 | 2.813 | ||||||
| 2018-02-05 | 2018-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | 120.000 | 120.000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70.000 | 70.000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70.000 | 70.000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40.000 | 40.000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,4800 | 818 | 3 | 29.280 | ||||
| 2018-02-05 | 2017-05-12 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 1,7000 | 761 | 1 | 28.462 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40.000 | 40.000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,4800 | 4.461 | 16 | 4.461 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70.000 | 70.000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | 16.000 | 16.000 | |||||
| 2017-09-01 | 2017-08-31 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | 525.000 | 525.000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20.000 | 20.000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20.000 | 20.000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20.000 | 20.000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20.000 | 20.000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,96 | 45.000 | 45.000 | |||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9.956 | ||||||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9.956 | ||||||||
| 2017-02-07 | 2017-02-06 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 5,09 | 30.000 | 30.000 | |||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55.402 | ||||||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55.402 | ||||||||
| 2017-02-02 | 2017-01-26 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 73.000 | 73.000 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | 172.500 | 172.500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57.500 | 57.500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100.625 | 100.625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100.625 | 100.625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57.500 | 57.500 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 0,99 | -42.424 | 0 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Common Stock | D | 0,9900 | 42.424 | 42 | 42.424 | ||||
| 2016-12-30 | 2014-02-19 | 4/A | KISNER DANIEL L | CNAT | Common Stock | I | 3.145 | 3.145 | ||||||
| 2016-12-30 | 2016-12-28 | 4 | KISNER DANIEL L | CNAT | Common Stock | I | 2.310 | 5.455 | ||||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | -5.051 | 207.070 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,24 | -36.363 | 0 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 5.051 | 5 | 41.414 | ||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 1,2400 | 36.363 | 45 | 36.363 | ||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,25 | -18.181 | 0 | |||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Common Stock | D | 0,2500 | 18.181 | 5 | 18.181 | ||||
| 2016-06-27 | 2016-06-23 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20.000 | 20.000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,13 | 45.000 | 45.000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20.000 | 20.000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20.000 | 20.000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20.000 | 20.000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20.000 | 20.000 | |||||
| 2016-04-04 | 2016-04-01 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,53 | 100.000 | 100.000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 37.500 | 37.500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 187.500 | 187.500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 12.500 | 12.500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 50.000 | 50.000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21.875 | 21.875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109.375 | 109.375 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21.875 | 21.875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109.375 | 109.375 | |||||
| 2015-06-15 | 2015-06-11 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 5,52 | 35.000 | 35.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15.000 | 15.000 | |||||
| 2015-04-10 | 2015-04-08 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 5,7500 | 4.000 | 23 | 7.145 | ||||
| 2015-02-25 | 2015-02-23 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50.000 | 50.000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50.000 | 50.000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 150.000 | 150.000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | 100.000 | 100.000 | |||||
| 2015-02-06 | 2014-04-02 | 5 | Cashion Charles See footnote. | CNAT | Common Stock | I | -5.000 | 144.738 | ||||||
| 2014-10-03 | 2014-10-01 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,92 | 175.000 | 175.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 7,97 | 35.000 | 35.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15.000 | 15.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15.000 | 15.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15.000 | 15.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15.000 | 15.000 | |||||
| 2014-02-25 | 2014-02-19 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 3.145 | 3.145 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | -36.634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36.634 | 36.634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | -30.216 | 22.203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | -1.283.589 | 943.355 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Klingenstein-Bole 2003 Irrevocable Children's Trust | CNAT | Common Stock | I | 8.731 | 8.731 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H | CNAT | Common Stock | D | 20.322 | 20.322 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | -36.634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36.634 | 36.634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | -30.216 | 22.203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | -1.283.589 | 943.355 | ||||||
| 2014-02-11 | 2014-02-07 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30.000 | 30.000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | 400.000 | 400.000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50.000 | 50.000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30.000 | 30.000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50.000 | 50.000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | BURGESS GARY C. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50.000 | 50.000 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,99 | -12.121 | 0 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Common Stock | D | 0,9900 | 12.121 | 12 | 24.242 | ||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,31 | -12.121 | 0 | |||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Common Stock | D | 2,3100 | 12.121 | 28 | 12.121 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32.220 | 32.220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265.837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Series B Convertible Preferred Stock | I | -8.333.334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 165.265 | 1.818 | 1.192.080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 16.716 | 184 | 1.026.815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 1.010.099 | 1.010.099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -577.599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series B Preferred Stock | I | -5.576.786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series A Preferred Stock | I | -10.000.000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 11,0000 | 190.054 | 2.091 | 2.166.836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | 19.223 | 211 | 1.976.782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | -535 | -6 | 1.957.559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 0,0825 | 70.003 | 6 | 1.958.094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 1.888.091 | 1.888.091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 11,00 | 50.000 | 50.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Series A Preferred Stock | I | -162.356 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 2.588 | 28 | 143.739 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 261 | 3 | 141.151 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 19.679 | 140.890 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Series B Preferred Stock | I | -5.555.556 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 123.950 | 1.363 | 809.887 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 12.537 | 138 | 685.937 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 673.400 | 673.400 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -577.599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series B Preferred Stock | I | -5.576.786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series A Preferred Stock | I | -10.000.000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 190.054 | 2.091 | 2.166.836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 19.223 | 211 | 1.976.782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | -535 | -6 | 1.957.559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 0,0825 | 70.003 | 6 | 1.958.094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Common Stock | I | 1.888.091 | 1.888.091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Series A Preferred Stock | I | -786.417 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 13.800 | 152 | 385.669 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 1.395 | 15 | 371.869 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 95.323 | 370.474 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Series A Preferred Stock | I | -355.352 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Common Stock | I | 43.072 | 149.738 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | -385.070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series B Preferred Stock | I | -3.717.861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series A Preferred Stock | I | -6.666.668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 165.525 | 1.821 | 1.487.320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 16.742 | 184 | 1.321.795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | -352 | -4 | 1.305.053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 46.675 | 1.305.405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 1.258.730 | 1.258.730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32.220 | 32.220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265.837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Series B Convertible Preferred Stock | I | -8.333.334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 165.265 | 1.818 | 1.192.080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 16.716 | 184 | 1.026.815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 1.010.099 | 1.010.099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32.220 | 32.220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | -265.837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Series B Convertible Preferred Stock | I | -8.333.334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 165.265 | 1.818 | 1.192.080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 16.716 | 184 | 1.026.815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 1.010.099 | 1.010.099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Series A Preferred Stock | I | -363.927 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Common Stock | I | 44.112 | 235.021 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | D | -385.070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series B Preferred Stock | D | -3.717.861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series A Preferred Stock | D | -6.666.668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 165.525 | 1.821 | 1.487.320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 16.742 | 184 | 1.321.795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | -352 | -4 | 1.305.053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 46.675 | 1.305.405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 1.258.730 | 1.258.730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | -997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -1.727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1.727 | 1.727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -5.701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -8.552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | -137.626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | -246.775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5.131 | 5.131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | -42.336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -73.395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73.395 | 73.395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -242.205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -363.308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | -5.846.236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | -10.483.166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2.470 | 27 | 52.419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49.949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | -14 | -0 | 49.698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1.727 | 0 | 49.712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46.594 | 47.985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104.952 | 1.154 | 2.226.944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10.614 | 117 | 2.121.992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | -552 | -6 | 2.111.378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73.395 | 6 | 2.111.930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1.979.321 | 2.038.535 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H | CNAT | Stock Option (right to buy) | D | 11,00 | 30.000 | 30.000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | -997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -1.727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1.727 | 1.727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -5.701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -8.552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | -137.626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | -246.775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5.131 | 5.131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | -42.336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | -73.395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73.395 | 73.395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -242.205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | -363.308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | -5.846.236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | -10.483.166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2.470 | 27 | 52.419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49.949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | -14 | -0 | 49.698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1.727 | 0 | 49.712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46.594 | 47.985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104.952 | 1.154 | 2.226.944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10.614 | 117 | 2.121.992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | -552 | -6 | 2.111.378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73.395 | 6 | 2.111.930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1.979.321 | 2.038.535 | ||||||
| 2013-07-24 | 3 | HALE DAVID F | CNAT | Common Stock | I | 121.211 | ||||||||
| 2013-07-24 | 3 | Mento Steven J | CNAT | Common Stock | I | 275.151 | ||||||||
| 2013-07-24 | 3 | Cashion Charles | CNAT | Common Stock | I | 106.666 | ||||||||
| 2013-07-24 | 3 | Spada Alfred P. | CNAT | Common Stock | I | 190.909 | ||||||||
| 2013-07-24 | 3 | BURGESS GARY C. | CNAT | Common Stock | D | 121.212 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1.391 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59.214 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1.391 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59.214 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
